Better use of public health facilities in India could improve kala-azar diagnosis, say researchersBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1769 (Published 31 March 2015) Cite this as: BMJ 2015;350:h1769
- Sanjeet Bagcchi
International experts have urged greater public-private partnership to facilitate the early diagnosis of kala-azar (visceral leishmaniasis) in the Indian state of Bihar to prevent delays in detecting cases and to reduce the transmission of the disease.
A team of experts led by Jan Boettcher, from the Centre for Biological Threats and Special Pathogens at the Robert Koch-Institute, Berlin, noted that over 66% of the world’s cases of kala-azar were reported in India, Nepal, and Bangladesh. In these countries nearly 147 million people are at risk of contracting kala-azar, and around 40 000 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial